<DOC>
	<DOCNO>NCT00412789</DOCNO>
	<brief_summary>The study evaluate safety efficacy Patupilone adult patient advance solid tumor .</brief_summary>
	<brief_title>Efficacy Safety Patupilone Patients With Advanced Solid Tumors Japan</brief_title>
	<detailed_description />
	<mesh_term>Epothilone B</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Inclusion criterion : Patients histologically/cytologically confirm diagnosis advance solid tumor refractory unsuitable standard therapy , standard therapy exist Patients WHO Performance Status 01 ( Karnofsky Performance Status 80100 ) At least one measurable lesion Exclusion criterion : Patients peripheral neuropathy Patients unresolved diarrhea Patients severe and/or uncontrolled medical condition infection require systemic therapy Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Advanced solid tumor</keyword>
	<keyword>Patupilone</keyword>
</DOC>